Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 280 entries
Sorted by: Best Match Show Resources per page
Electrophysiological Advances on Multiple Object Processing in Aging.

Frontiers in aging neuroscience

Mazza V, Brignani D.
PMID: 26973520
Front Aging Neurosci. 2016 Mar 02;8:46. doi: 10.3389/fnagi.2016.00046. eCollection 2016.

EEG research conducted in the past 5 years on multiple object processing has begun to define how the aging brain tracks the numerosity of the objects presented in the visual field for different goals. We review the recent EEG...

Cite
Mazza V, Brignani D. Electrophysiological Advances on Multiple Object Processing in Aging. Front Aging Neurosci. 2016;8:46doi: 10.3389/fnagi.2016.00046.
Mazza, V., & Brignani, D. (2016). Electrophysiological Advances on Multiple Object Processing in Aging. Frontiers in aging neuroscience, 846. https://doi.org/10.3389/fnagi.2016.00046
Mazza, Veronica, and Brignani, Debora. "Electrophysiological Advances on Multiple Object Processing in Aging." Frontiers in aging neuroscience vol. 8 (2016): 46. doi: https://doi.org/10.3389/fnagi.2016.00046
Mazza V, Brignani D. Electrophysiological Advances on Multiple Object Processing in Aging. Front Aging Neurosci. 2016 Mar 02;8:46. doi: 10.3389/fnagi.2016.00046. eCollection 2016. PMID: 26973520; PMCID: PMC4773734.
Copy Download .nbib Format: NLM
MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Pharmacogenomics and personalized medicine

Cipollini M, Landi S, Gemignani F.
PMID: 25114582
Pharmgenomics Pers Med. 2014 Jul 23;7:173-91. doi: 10.2147/PGPM.S61693. eCollection 2014.

MicroRNAs (miRNAs) are important regulators of eukaryotic gene expression. They have been implicated in a broad range of biological processes, and miRNA-related genetic alterations probably underlie several human diseases. Single nucleotide polymorphisms of transcripts may modulate the posttranscriptional regulation...

Cite
Cipollini M, Landi S, Gemignani F. MicroRNA binding site polymorphisms as biomarkers in cancer management and research. Pharmgenomics Pers Med. 2014;7:173-91doi: 10.2147/PGPM.S61693.
Cipollini, M., Landi, S., & Gemignani, F. (2014). MicroRNA binding site polymorphisms as biomarkers in cancer management and research. Pharmacogenomics and personalized medicine, 7173-91. https://doi.org/10.2147/PGPM.S61693
Cipollini, Monica, et al. "MicroRNA binding site polymorphisms as biomarkers in cancer management and research." Pharmacogenomics and personalized medicine vol. 7 (2014): 173-91. doi: https://doi.org/10.2147/PGPM.S61693
Cipollini M, Landi S, Gemignani F. MicroRNA binding site polymorphisms as biomarkers in cancer management and research. Pharmgenomics Pers Med. 2014 Jul 23;7:173-91. doi: 10.2147/PGPM.S61693. eCollection 2014. PMID: 25114582; PMCID: PMC4126202.
Copy Download .nbib Format: NLM
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.

Case reports in immunology

Urraro T, Gragnani L, Piluso A, Fabbrizzi A, Monti M, Fognani E, Boldrini B, Ranieri J, Zignego AL.
PMID: 25815218
Case Reports Immunol. 2015;2015:816424. doi: 10.1155/2015/816424. Epub 2015 Mar 01.

Mixed cryoglobulinemia (MC) is an autoimmune/B-cell lymphoproliferative disorder associated with Hepatitis C Virus (HCV) infection, manifesting as a systemic vasculitis. In the last decade, antiviral treatment (AT) with pegylated interferon (Peg-IFN) plus ribavirin (RBV) was considered the first therapeutic...

Cite
Urraro T, Gragnani L, Piluso A, et al. Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy. Case Reports Immunol. 2015;2015:816424doi: 10.1155/2015/816424.
Urraro, T., Gragnani, L., Piluso, A., Fabbrizzi, A., Monti, M., Fognani, E., Boldrini, B., Ranieri, J., & Zignego, A. L. (2015). Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy. Case reports in immunology, 2015816424. https://doi.org/10.1155/2015/816424
Urraro, Teresa, et al. "Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy." Case reports in immunology vol. 2015 (2015): 816424. doi: https://doi.org/10.1155/2015/816424
Urraro T, Gragnani L, Piluso A, Fabbrizzi A, Monti M, Fognani E, Boldrini B, Ranieri J, Zignego AL. Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy. Case Reports Immunol. 2015;2015:816424. doi: 10.1155/2015/816424. Epub 2015 Mar 01. PMID: 25815218; PMCID: PMC4359800.
Copy Download .nbib Format: NLM
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice.

Therapeutic advances in medical oncology

Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA.
PMID: 29449894
Ther Adv Med Oncol. 2017 Dec;9(12):731-739. doi: 10.1177/1758834017742627. Epub 2017 Dec 19.

BACKGROUND: Regorafenib (REG) has now been approved as the standard third-line therapy in metastatic gastrointestinal stromal tumour (GIST) patients at the recommended dose and schedule of 160 mg once daily for the first 3 weeks of each 4-week cycle....

Cite
Nannini M, Nigro MC, Vincenzi B, et al. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017;9(12):731-739doi: 10.1177/1758834017742627.
Nannini, M., Nigro, M. C., Vincenzi, B., Fumagalli, E., Grignani, G., D'Ambrosio, L., Badalamenti, G., Incorvaia, L., Bracci, R., Gasperoni, S., Saponara, M., Gatto, L., Indio, V., Astolfi, A., Di Scioscio, V., Casali, P. G., Tonini, G., Aglietta, M., Russo, A., Biasco, G., & Pantaleo, M. A. (2017). Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Therapeutic advances in medical oncology, 9(12), 731-739. https://doi.org/10.1177/1758834017742627
Nannini, Margherita, et al. "Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice." Therapeutic advances in medical oncology vol. 9,12 (2017): 731-739. doi: https://doi.org/10.1177/1758834017742627
Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017 Dec;9(12):731-739. doi: 10.1177/1758834017742627. Epub 2017 Dec 19. PMID: 29449894; PMCID: PMC5808843.
Copy Download .nbib Format: NLM
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.

Open access journal of urology

Berruti A, Vignani F, Russo L, Bertaglia V, Tullio M, Tucci M, Poggio M, Dogliotti L.
PMID: 24198620
Open Access J Urol. 2010 Jul 23;2:109-24. doi: 10.2147/rru.s6573.

Neuroendocrine (NE) differentiation is a common feature in prostate cancer (PC). The clinical significance of this phenomenon is controversial; however preclinical and clinical data are in favor of an association with poor prognosis and early onset of a castrate...

Cite
Berruti A, Vignani F, Russo L, et al. Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. Open Access J Urol. 2010;2:109-24doi: 10.2147/rru.s6573.
Berruti, A., Vignani, F., Russo, L., Bertaglia, V., Tullio, M., Tucci, M., Poggio, M., & Dogliotti, L. (2010). Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. Open access journal of urology, 2109-24. https://doi.org/10.2147/rru.s6573
Berruti, Alfredo, et al. "Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle." Open access journal of urology vol. 2 (2010): 109-24. doi: https://doi.org/10.2147/rru.s6573
Berruti A, Vignani F, Russo L, Bertaglia V, Tullio M, Tucci M, Poggio M, Dogliotti L. Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. Open Access J Urol. 2010 Jul 23;2:109-24. doi: 10.2147/rru.s6573. PMID: 24198620; PMCID: PMC3818883.
Copy Download .nbib Format: NLM
Sister Mary Joseph node.

QJM : monthly journal of the Association of Physicians

Prignano F, Lazzeri L, Massi D.
PMID: 28398511
QJM. 2017 Jul 01;110(7):473. doi: 10.1093/qjmed/hcx075.

No abstract available.

Cite
Prignano F, Lazzeri L, Massi D. Sister Mary Joseph node. QJM. 2017;110(7):473doi: 10.1093/qjmed/hcx075.
Prignano, F., Lazzeri, L., & Massi, D. (2017). Sister Mary Joseph node. QJM : monthly journal of the Association of Physicians, 110(7), 473. https://doi.org/10.1093/qjmed/hcx075
Prignano, F, et al. "Sister Mary Joseph node." QJM : monthly journal of the Association of Physicians vol. 110,7 (2017): 473. doi: https://doi.org/10.1093/qjmed/hcx075
Prignano F, Lazzeri L, Massi D. Sister Mary Joseph node. QJM. 2017 Jul 01;110(7):473. doi: 10.1093/qjmed/hcx075. PMID: 28398511.
Copy Download .nbib Format: NLM
Tap Water has No Influence on Microbial Colonization of Skin Wounds in Rats.

Wounds : a compendium of clinical research and practice

Resende M, Hochman B, Gragnani A, Viega DF, Damasceno C, Juliano Y, Ferreira L.
PMID: 25874708
Wounds. 2012 Sep;24(9):275-82.

UNLABELLED:  The aim of this study was to investigate the influence of tap water on microbial colonization of skin wounds in rats.METHODS: A cir- cular wound 2.4 cm in diameter was created on the back of 40 Wistar...

Cite
Resende M, Hochman B, Gragnani A, et al. Tap Water has No Influence on Microbial Colonization of Skin Wounds in Rats. Wounds. 2012;24(9):275-82
Resende, M., Hochman, B., Gragnani, A., Viega, D. F., Damasceno, C., Juliano, Y., & Ferreira, L. (2012). Tap Water has No Influence on Microbial Colonization of Skin Wounds in Rats. Wounds : a compendium of clinical research and practice, 24(9), 275-82.
Resende, Margarida, et al. "Tap Water has No Influence on Microbial Colonization of Skin Wounds in Rats." Wounds : a compendium of clinical research and practice vol. 24,9 (2012): 275-82.
Resende M, Hochman B, Gragnani A, Viega DF, Damasceno C, Juliano Y, Ferreira L. Tap Water has No Influence on Microbial Colonization of Skin Wounds in Rats. Wounds. 2012 Sep;24(9):275-82. PMID: 25874708.
Copy Download .nbib Format: NLM
Microarray as a new tool to study hypertrophic and keloid scarring.

Wounds : a compendium of clinical research and practice

Luiza Ramos M, Gragnani A, Masako Ferreira L.
PMID: 25903026
Wounds. 2009 Feb;21(2):57-63.

UNLABELLED:  Background. Normal wound healing results from a complex set of reactions between blood cells, skin cells, and biochemical mediators including pro- and anti-inflammatory molecules, growth factors, cytokines, hormones, and vitamins. As this cascade of reactions is ultimately...

Cite
Luiza Ramos M, Gragnani A, Masako Ferreira L. Microarray as a new tool to study hypertrophic and keloid scarring. Wounds. 2009;21(2):57-63
Luiza Ramos, M., Gragnani, A., & Masako Ferreira, L. (2009). Microarray as a new tool to study hypertrophic and keloid scarring. Wounds : a compendium of clinical research and practice, 21(2), 57-63.
Luiza Ramos, Maria, et al. "Microarray as a new tool to study hypertrophic and keloid scarring." Wounds : a compendium of clinical research and practice vol. 21,2 (2009): 57-63.
Luiza Ramos M, Gragnani A, Masako Ferreira L. Microarray as a new tool to study hypertrophic and keloid scarring. Wounds. 2009 Feb;21(2):57-63. PMID: 25903026.
Copy Download .nbib Format: NLM
Flow cytometry of human primary epidermal and follicular keratinocytes.

Eplasty

Gragnani A, Ipolito MZ, Sobral CS, Brunialti MK, Salomão R, Ferreira LM.
PMID: 18350110
Eplasty. 2008 Feb 19;8:e14.

OBJECTIVE: The aim of this study was to characterize using flow cytometry cultured human primary keratinocytes isolated from the epidermis and hair follicles by different methods.METHODS: Human keratinocytes derived from discarded fragments of total skin and scalp hair follicles...

Cite
Gragnani A, Ipolito MZ, Sobral CS, et al. Flow cytometry of human primary epidermal and follicular keratinocytes. Eplasty. 2008;8:e14
Gragnani, A., Ipolito, M. Z., Sobral, C. S., Brunialti, M. K., Salomão, R., & Ferreira, L. M. (2008). Flow cytometry of human primary epidermal and follicular keratinocytes. Eplasty, 8e14.
Gragnani, Alfredo, et al. "Flow cytometry of human primary epidermal and follicular keratinocytes." Eplasty vol. 8 (2008): e14.
Gragnani A, Ipolito MZ, Sobral CS, Brunialti MK, Salomão R, Ferreira LM. Flow cytometry of human primary epidermal and follicular keratinocytes. Eplasty. 2008 Feb 19;8:e14. PMID: 18350110; PMCID: PMC2258552.
Copy Download .nbib Format: NLM
Human keratinocytes cultured on collagen matrix used as an experimental burn model.

Journal of burns and wounds

Sobral CS, Gragnani A, Cao X, Morgan JR, Ferreira LM.
PMID: 18091983
J Burns Wounds. 2007 Oct 30;7:e6.

BACKGROUND: In experimental models in vivo, it is difficult to characterize the effect of thermal burns on epidermal keratinocytes. Since the response to thermal injury involves several systemic mechanisms, especially because of the stimulus to coagulation and inflammatory cascades,...

Cite
Sobral CS, Gragnani A, Cao X, et al. Human keratinocytes cultured on collagen matrix used as an experimental burn model. J Burns Wounds. 2007;7:e6
Sobral, C. S., Gragnani, A., Cao, X., Morgan, J. R., & Ferreira, L. M. (2007). Human keratinocytes cultured on collagen matrix used as an experimental burn model. Journal of burns and wounds, 7e6.
Sobral, Christiane S, et al. "Human keratinocytes cultured on collagen matrix used as an experimental burn model." Journal of burns and wounds vol. 7 (2007): e6.
Sobral CS, Gragnani A, Cao X, Morgan JR, Ferreira LM. Human keratinocytes cultured on collagen matrix used as an experimental burn model. J Burns Wounds. 2007 Oct 30;7:e6. PMID: 18091983; PMCID: PMC2064970.
Copy Download .nbib Format: NLM
In vitro Effect of Verapamil on Platelet Activation Induced by ADP, Collagen or Thrombin.

Platelets

Brocchieri A, Pacchiarini L, Saporiti A, Grignani G.
PMID: 21043728
Platelets. 1995;6(4):195-9. doi: 10.3109/09537109509078454.

We studied the effects in Vitro of the calcium channel blocker verapamil (0.1, 0.2 or 0.3 mM) on platelet aggregation, on cytoplasmic Ca(+ +) levels and on TxB(2) production after activation of platelets with adenosine diphosphate (ADP) (100 µM),...

Cite
Brocchieri A, Pacchiarini L, Saporiti A, et al. In vitro Effect of Verapamil on Platelet Activation Induced by ADP, Collagen or Thrombin. Platelets. 1995;6(4):195-9doi: 10.3109/09537109509078454.
Brocchieri, A., Pacchiarini, L., Saporiti, A., & Grignani, G. (1995). In vitro Effect of Verapamil on Platelet Activation Induced by ADP, Collagen or Thrombin. Platelets, 6(4), 195-9. https://doi.org/10.3109/09537109509078454
Brocchieri, A, et al. "In vitro Effect of Verapamil on Platelet Activation Induced by ADP, Collagen or Thrombin." Platelets vol. 6,4 (1995): 195-9. doi: https://doi.org/10.3109/09537109509078454
Brocchieri A, Pacchiarini L, Saporiti A, Grignani G. In vitro Effect of Verapamil on Platelet Activation Induced by ADP, Collagen or Thrombin. Platelets. 1995;6(4):195-9. doi: 10.3109/09537109509078454. PMID: 21043728.
Copy Download .nbib Format: NLM
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study.

Oncology letters

Santoni M, Paccapelo A, Burattini L, Bianconi M, Cardinali M, Fabbietti L, Trignani R, Rychlicki F, Cascinu S.
PMID: 23205103
Oncol Lett. 2012 Oct;4(4):799-801. doi: 10.3892/ol.2012.788. Epub 2012 Jul 05.

O(6)-alkylguanine-DNA alkyltransferase (AGAT), involved in temozolomide-induced DNA damage repair, plays a key role in the efficacy of temozolomide. AGAT activity may be reduced by protracted temozolomide doses. On the basis of the preclinical findings, we treated patients with a...

Cite
Santoni M, Paccapelo A, Burattini L, et al. Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. Oncol Lett. 2012;4(4):799-801doi: 10.3892/ol.2012.788.
Santoni, M., Paccapelo, A., Burattini, L., Bianconi, M., Cardinali, M., Fabbietti, L., Trignani, R., Rychlicki, F., & Cascinu, S. (2012). Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. Oncology letters, 4(4), 799-801. https://doi.org/10.3892/ol.2012.788
Santoni, Matteo, et al. "Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study." Oncology letters vol. 4,4 (2012): 799-801. doi: https://doi.org/10.3892/ol.2012.788
Santoni M, Paccapelo A, Burattini L, Bianconi M, Cardinali M, Fabbietti L, Trignani R, Rychlicki F, Cascinu S. Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. Oncol Lett. 2012 Oct;4(4):799-801. doi: 10.3892/ol.2012.788. Epub 2012 Jul 05. PMID: 23205103; PMCID: PMC3506588.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 280 entries